A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
出版年份 2023 全文链接
标题
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 12, Issue 2, Pages 599
出版商
MDPI AG
发表日期
2023-01-12
DOI
10.3390/jcm12020599
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Drug-tolerant persister cells in cancer therapy resistance
- (2022) Pavan Kumar. Dhanyamraju et al. CANCER RESEARCH
- Intermittent treatment of BRAF V600E melanoma cells delays resistance by adaptive resensitization to drug rechallenge
- (2022) Andrew J. Kavran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes
- (2022) Jingsong Zhang et al. eLife
- Addressing Drug Resistance in Cancer: A Team Medicine Approach
- (2022) Prakash Kulkarni et al. Journal of Clinical Medicine
- Mutations of Intrinsically Disordered Protein Regions Can Drive Cancer but Lack Therapeutic Strategies
- (2021) Bálint Mészáros et al. Biomolecules
- A non-genetic, cell cycle dependent mechanism of platinum resistance in lung adenocarcinoma
- (2021) Alvaro Gonzalez Rajal et al. eLife
- Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy
- (2021) Arin Nam et al. Biomolecules
- An evolutionary framework for treating pediatric sarcomas
- (2020) Damon R. Reed et al. CANCER
- Challenges and Opportunities in Cancer Drug Resistance
- (2020) Richard A. Ward et al. CHEMICAL REVIEWS
- Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
- (2020) Marlon Perera et al. Nature Reviews Urology
- A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer
- (2020) Atish Mohanty et al. iScience
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Principles and mechanisms of non-genetic resistance in cancer
- (2019) Charles C. Bell et al. BRITISH JOURNAL OF CANCER
- A Convergence-Based Framework for Cancer Drug Resistance
- (2018) David J. Konieczkowski et al. CANCER CELL
- Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight
- (2018) K. Lohitesh et al. Cancer Cell International
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Optimizing Cancer Treatment Using Game Theory
- (2018) Katerina Stanková et al. JAMA Oncology
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
- (2017) Dimakatso Alice Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paxillin: a crossroad in pathological cell migration
- (2017) Ana María López-Colomé et al. Journal of Hematology & Oncology
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
- (2017) Matthew J. Hangauer et al. NATURE
- Epigenetic plasticity and the hallmarks of cancer
- (2017) William A. Flavahan et al. SCIENCE
- Cell matrix adhesions in cancer: The proteins that form the glue
- (2017) Mazvita Maziveyi et al. Oncotarget
- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Drug Resistance to EGFR Inhibitors in Lung Cancer
- (2016) Osamu Tetsu et al. CHEMOTHERAPY
- Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma
- (2016) Ravi Salgia EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Deciphering Mode of Action of Functionally Important Regions in the Intrinsically Disordered Paxillin (Residues 1-313) Using Its Interaction with FAT (Focal Adhesion Targeting Domain of Focal Adhesion Kinase)
- (2016) Muniasamy Neerathilingam et al. PLoS One
- Mechanisms of resistance to third-generation EGFR tyrosine kinase inhibitors
- (2016) Shuhang Wang et al. Frontiers of Medicine
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- Application of Evolutionary Principles to Cancer Therapy
- (2015) P. M. Enriquez-Navas et al. CANCER RESEARCH
- Erratum: A stress-induced early innate response causes multidrug tolerance in melanoma
- (2015) D Ravindran Menon et al. ONCOGENE
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Signalling pathways linking integrins with cell cycle progression
- (2013) Paulina Moreno-Layseca et al. MATRIX BIOLOGY
- High drug attrition rates—where are we going wrong?
- (2011) Lisa Hutchinson et al. Nature Reviews Clinical Oncology
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Cisplatin resistance: Preclinical findings and clinical implications
- (2010) Beate Köberle et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease
- (2010) A. C. Mackinnon et al. JOURNAL OF CLINICAL PATHOLOGY
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation
- (2009) Ozgur Kutuk et al. CARCINOGENESIS
- Paxillin nuclear-cytoplasmic localization is regulated by phosphorylation of the LD4motif: evidence that nuclear paxillin promotes cell proliferation
- (2008) Jing-Ming Dong et al. BIOCHEMICAL JOURNAL
- EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation
- (2008) T. Trowe et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started